U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
149124
Substance Class Structurally Diverse
Created
by admin
on Tue Apr 01 20:40:12 GMT 2025
Edited
by admin
on Tue Apr 01 20:40:12 GMT 2025
Source Materials Class ORGANISM
Source Materials Type VIRUS
Organism Family Reoviridae
Organism Genus Orthoreovirus
Organism Species reovirus type 3
Author NONE
Infraspecific Type STRAIN
Infraspecific Name SEROTYPE Type 3 Dearing
Part whole
Record UNII
S9J80L3D1U
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
MAMMALIAN ORTHOREOVIRUS 3 STRAIN DEARING
Preferred Name English
PELAREOREP
USAN  
USAN  
Official Name English
T3D
Common Name English
REOLYSIN
Brand Name English
REOVIRUS (TYPE 3 / STRAIN DEARING)
Common Name English
PELAREOREP [USAN]
Common Name English
PO-BB0209
Code English
Pelareorep [WHO-DD]
Common Name English
REOVIRUS 3 (STRAIN DEARING)
Common Name English
REOVIRUS TYPE 3 (STRAIN DEARING) (T3D) (MAMMALIAN ORTHOREOVIRUS 3)
Common Name English
REOVIRUS TYPE 3 DEARING ONCOLYTIC VIRUS WITHOUT TRANSGENES
Common Name English
PO BB0209
Code English
REOVIRUS TYPE 3 (STRAIN DEARING)
Common Name English
PO-BB-0209
Code English
MAMMALIAN ORTHOREOVIRUS 3-DEARING
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C717
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
FDA ORPHAN DRUG 470215
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
FDA ORPHAN DRUG 464414
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
FDA ORPHAN DRUG 472915
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
FDA ORPHAN DRUG 478315
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
FDA ORPHAN DRUG 464514
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
EU-Orphan Drug EU/3/15/1469
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
FDA ORPHAN DRUG 470115
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
Code System Code Type Description
SMS_ID
100000168493
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
PRIMARY
ChEMBL
CHEMBL3545069
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
PRIMARY
CAS
1383626-61-6
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
PRIMARY
WIKIPEDIA
REOLYSIN
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
PRIMARY
USAN
AB-12
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
PRIMARY
EVMPD
SUB181875
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
PRIMARY
NCI_THESAURUS
C60774
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
PRIMARY
FDA UNII
S9J80L3D1U
Created by admin on Tue Apr 01 20:40:12 GMT 2025 , Edited by admin on Tue Apr 01 20:40:12 GMT 2025
PRIMARY
Related Record Type Details
PELAREOREP
ACTIVE MOIETY
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966